Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Knock-down and Over-expression of JMJD6 in MCF-7 and/or MDA-MB231

ABSTRACT: By survival analysis of breast cancer patients, JMJD6 was found to be significantly associated with poor prognosis. Over-expression and knock-down of JMJD6 in breast cancer cell lines suggested a role in proliferation. In order to study the transcriptional events that occur following JMJD6 expression changes, siRNA-mediated knock-down of JMJD6 was performed in MCF-7 and MDA-MB231 and stable over-expression of JMJD6 was performed in MCF-7. There are 2 different siRNA-mediated knock-downs of JMJD6 with 2 biological replicates in MCF-7 and MDA-MB231; 3 clones of JMJD6 over-expression with 3 biological replicates in MCF-7. The control for the knock-downs is scrambled siRNA-treated MCF-7 and MDA-MB231 and the control for JMJD6 over-expression is empty vector over-expression in MCF-7.

ORGANISM(S): Homo sapiens

SUBMITTER: Yi Fang Lee 

PROVIDER: E-GEOD-31782 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.

Lee Yi Fang YF   Miller Lance David LD   Chan Xiu Bin XB   Black Michael A MA   Pang Brendan B   Ong Chee Wee CW   Salto-Tellez Manuel M   Liu Edison T ET   Desai Kartiki V KV  

Breast cancer research : BCR 20120523 3

<h4>Introduction</h4>We developed an analytic strategy that correlates gene expression and clinical outcomes as a means to identify novel candidate oncogenes operative in breast cancer. This analysis, followed by functional characterization, resulted in the identification of Jumonji Domain Containing 6 (JMJD6) protein as a novel driver of oncogenic properties in breast cancer.<h4>Methods</h4>Through microarray informatics, Cox proportional hazards regression was used to analyze the correlation b  ...[more]

Similar Datasets

Unknown Knock-down and Over-expression of JMJD6 in MCF-7 and/or MDA-MB231
2012-05-10 | GSE31782 | GEO
Transcriptomics Transcriptomic analysis of ERR alpha orphan nuclear receptor
2014-09-17 | E-GEOD-49110 | biostudies-arrayexpress
Transcriptomics siRNA-mediated HNRPA2B1 knock-down in MDA-MB-231 cells
2012-02-28 | E-GEOD-35757 | biostudies-arrayexpress
Genomics,Multiomics Homo sapiens
| PRJNA145293 | ENA
Transcriptomics Effect of PIAS1 on gene expression
2014-02-06 | E-GEOD-44024 | biostudies-arrayexpress
Transcriptomics Expression profiling of hypoxic HepG2 hepatoma, U87 glioma, and MDA-MB231 breast cancer cells: time course
2010-06-21 | E-GEOD-18494 | biostudies-arrayexpress
Transcriptomics The effect of MFNG knockdown on gene expression profile of xenograft tumor derived from MDA-MB231 cells
2015-05-01 | E-GEOD-62481 | biostudies-arrayexpress
Proteomics Intensity-based absolute quantification (iBAQ) of proteins in MDA-MB231
2021-05-14 | PXD024139 | Pride
Transcriptomics Whole-genome decay rate measurements in MDA-MB-231 cells transfected with HNRPA2B1 siRNAs versus controls
2012-02-28 | E-GEOD-35756 | biostudies-arrayexpress
Genomics,Multiomics E-GEOD-31782
2015-08-17 | E-GEOD-31782 | ExpressionAtlas